Dr. Roman Simon

Dr. Roman Simon

Post-doc – Drug Discovery Sciences

PhD in Pharmaceutical and Medicinal Chemistry, University of Freiburg (Germany)


Our work focuses on the implementation of mass spectrometry-based, physiologically relevant label-free in vitro assays in drug discovery. Mass spectrometry (MS) is an emerging technology for identifying and characterizing molecules that modulate protein function offering a label-free, direct detection method. We utilize recent advances in liquid handling technology for developing high-throughput capable MS-based readout strategies for small molecule screening and profiling campaigns.


Dr. Wolfgang Reindl

Dr. Wolfgang Reindl

Laboratory Head – Drug Discovery Sciences

PhD in Biochemistry, Max Planck Institute of Biochemistry Martinsried (Germany)

Research interests:

  • Assay development, high-throughput screening and compound profiling
  • High-throughput MALDI-TOF MS
  • Covalent inhibitors